novo nordisk lawsuit semaglutide drops against Hims & Hers over off-brand weight loss medications, enter collaboration Ozempic Lawsuits Facing $2 Billion

Why it matters: Cardiovascular disease is the leading cause of death globally

Catalpol promotes mitochondrial biogenesis in chondrocytes

Why Choose MintRX Glutathione Nasal Spray

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), a category of antidiabetic medications such as semaglutide and liraglutide, have dramatically improved outcomes in the treatment of T2D and obesity, significantly reducing complications from their metabolic consequences including cardiovascular and chronic kidney disease [20, 21]

Microdosing protocols are off-label and should be discussed with your prescriber

FIGURE 3 5.1 Anti-aging As age progresses, the risk of cardiovascular diseases, including atrial and ventricular arrhythmias, rises significantly